Invention Grant
- Patent Title: Monomeric CXCL121 peptide and methods of treating autoimmune diseases
-
Application No.: US15874476Application Date: 2018-01-18
-
Publication No.: US10537613B2Publication Date: 2020-01-21
- Inventor: Brian Volkman , Joshua Ziarek , Christopher Veldkamp , Francis Peterson
- Applicant: The Medical College of Wisconsin, Inc.
- Applicant Address: US WI Milwaukee
- Assignee: The Medical College of Wisconsin, Inc.
- Current Assignee: The Medical College of Wisconsin, Inc.
- Current Assignee Address: US WI Milwaukee
- Agency: Quarles & Brady LLP
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61K38/19 ; C07K14/52
Abstract:
The present invention provides a CXCL121 peptide engineered to resist peptide-induced dimerization by maintaining steric repulsion of the chemokine helix, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of cancer, inflammatory disorders, autoimmune disease, and HIV/AIDS.
Public/Granted literature
- US20180148490A1 MONOMERIC CXCL121 PEPTIDE AND USE THEREOF Public/Granted day:2018-05-31
Information query
IPC分类:
